Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Accumulated Expenses (2019 - 2025)

Historic Accumulated Expenses for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $14.9 million.

  • Pulmonx's Accumulated Expenses rose 1687.93% to $14.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.9 million, marking a year-over-year increase of 1687.93%. This contributed to the annual value of $16.5 million for FY2024, which is 146.61% up from last year.
  • Latest data reveals that Pulmonx reported Accumulated Expenses of $14.9 million as of Q3 2025, which was up 1687.93% from $14.4 million recorded in Q2 2025.
  • Pulmonx's Accumulated Expenses' 5-year high stood at $16.5 million during Q4 2024, with a 5-year trough of $9.8 million in Q1 2021.
  • Over the past 5 years, Pulmonx's median Accumulated Expenses value was $12.4 million (recorded in 2021), while the average stood at $12.6 million.
  • Per our database at Business Quant, Pulmonx's Accumulated Expenses surged by 5450.24% in 2021 and then tumbled by 1317.28% in 2022.
  • Quarter analysis of 5 years shows Pulmonx's Accumulated Expenses stood at $13.4 million in 2021, then fell by 0.67% to $13.3 million in 2022, then grew by 22.28% to $16.2 million in 2023, then grew by 1.47% to $16.5 million in 2024, then dropped by 9.32% to $14.9 million in 2025.
  • Its Accumulated Expenses was $14.9 million in Q3 2025, compared to $14.4 million in Q2 2025 and $11.5 million in Q1 2025.